Related references
Note: Only part of the references are listed.CMV viral load kinetics as surrogate endpoints after allogenic transplantation
Elizabeth R. Duke et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation
Prashant Sharma et al.
BONE MARROW TRANSPLANTATION (2020)
Letermovir Prophylaxis Decreases Burden of Cytomegalovirus (CMV) in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant
Joyce J. Johnsrud et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation
Aimee E. Hammerstrom et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients
Joshua Aiden Hill et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients
Yoichiro Natori et al.
TRANSPLANTATION (2017)
Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies
Juliet N. Barker et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant
Parastoo B. Dahi et al.
LEUKEMIA & LYMPHOMA (2015)
Immune Reconstitution after Double Umbilical Cord Blood Stem Cell Transplantation: Comparison with Unrelated Peripheral Blood Stem Cell Transplantation
Caron A. Jacobson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Immune Recovery in Adult Patients after Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation
Junya Kanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients
Filippo Milano et al.
BLOOD (2011)
Impact of Cytomegalovirus (CMV) Reactivation after Umbilical Cord Blood Transplantation
Jill C. Beck et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing
Krishna V. Komanduri et al.
BLOOD (2007)
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
M Hakki et al.
BLOOD (2003)
Share Paper
